Eye drug Eylea has mysterious rise in side effect reports
Minneapolis
DOCTORS say they're seeing an unexplained increase in a rare, frightening side effect in patients getting Regeneron Pharmaceuticals' top-selling product, the blockbuster eye drug Eylea.
After the drug is injected into the eye, a small number of people have a sharp decline in sight, experience pain, and can panic. While the effect is treatable and doesn't lead to long-term vision loss, a professional society of eye physicians has warned members to look out for the condition.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Shareholders raise questions over dividend payout, directors’ salaries at Best World AGM ahead of proposed privatisation
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue